7 tumorer og i kombination med kemoterapi med og uden bevacizumab til patienter med mCRC eller i kombination med kemoterapi til patienter med ikke- småcellet lungecancer.
Additional studies were performed with Vectibix as a single agent in patients with other solid tumours and in combination with chemotherapy with and without bevacizumab in patients with mCRC or in combination with chemotherapy in patients with non-small cell lung cancer.